Back
line-webinar-slate-30px

Webinar

Synthetic DNA Technologies Enable Fast & Responsive Antibody Discovery & Optimization

PEGS Boston Virtual 2020 Presentation

Dr. Aaron Sato, CSO of Twist Biopharma, presentation from PEGS Boston Virtual 2020, Synthetic DNA Technologies Enable Fast & Responsive Antibody Discovery & Optimization.

  • How Dr. Sato isn’t settling for just a single phage display library, but is instead building a panel of highly diverse synthetic naïve antibody phage display libraries.
  • How those libraries are yielding results even against difficult-to-drug targets.
  • How we’ve taken our learnings to build the Twist Antibody Optimization (TAO) platform for antibody affinity and developability optimization.
  • Why Twist Biopharma is now in a position to offer high-throughput antibody expression as a service.